Pluristyx provides induced pluripotent stem cells and expertise to accelerate the development and commercialization of cellular therapies. The company offers a portfolio of non-modified and genetically engineered iPSC-based technologies and related services.

Pluristyx

Alacrita is a biotech consulting firm that offers R&D and business support services for the pharmaceutical and biotechnology industries, self-described as offering full-range specialist expertise.

Alacrita

Blue Matter Consulting is a consulting firm serving the life sciences industry. The firm claims to provide a new approach to consulting with original ideas and meaningful impact.

Blue Matter Consulting

MWA Consulting provides consulting expertise in quality systems and GXP compliance, focusing on innovative solutions for the pharmaceutical, medical device, and biotechnology industries, self-described as having high standards of excellence.

Metric
Company Name	Pluristyx	Alacrita	Blue Matter Consulting	MWA Consulting
Symbol
MSH ID	COM:PLURISTYX	COM:ALACRITA	COM:BLUEMATTERCONSULTING	COM:MWA-CONSULTING
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Commercial & Professional Services	Commercial & Professional Services	Commercial & Professional Services
Industry	Biotechnology	Biotechnology	Consulting	Consulting
Country	US	GB	US	US
Stage
Employee Count
Website	pluristyx.com	alacrita.com	bluematterconsulting.com	mwa-consulting.com
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:PLURISTYX

Pluristyx

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue